ArticleJournal of thoracic disease2025

Lower r-FEV1 as a predictor of treatment response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy.

Yuqi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.